A study of HA-1-specific CD8+ CTL showed that APCs coated with HLA-A*02:01/HA-1 stimulated CD8+ CTL (donor-derived HLA-A*02:01/HA-1−) to kill HA-1-positive cells in primary leukemia blasts (79). The gene discussed is CD8A; the disease is leukemia.